The Rabeprazole Sodium Tablets, cataloged under National Stock Number 6505-01-493-9575, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Taro Pharmaceuticals U.s.a., Inc.. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-493-9575 |
| Primary Part Number | NDC51407-0184-90 |
| Item Name | Rabeprazole Sodium Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Taro Pharmaceuticals U.s.a., Inc. |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC51407-0184-90 PRIMARY | Taro Pharmaceuticals U.s.a., Inc. (USA) |
| NDC62175-0302-46 | Ucb, Inc (USA) |
| Reference | Meaning |
|---|---|
| 01-0755 | 5/1 Secondary reference U.S. Government activity |
| NDC60429-0232-90 | 3/1 Design control — primary reference Mylan Pharmaceuticals Inc |
NSN 6505-01-493-9575 is a Rabeprazole Sodium Tablets, manufactured by Taro Pharmaceuticals U.s.a., Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-493-9575 has 2 manufacturer part numbers on file: NDC51407-0184-90 (Taro Pharmaceuticals U.s.a., Inc.), NDC62175-0302-46 (Ucb, Inc).
Key specifications for NDC51407-0184-90: Special Features: ACTIVE INGREDIENT IS 20 MG OF RABEPRAZOLE SODIUM THAT INHIBITS GASTRIC ACID SECRETION; BOTTLE CONTAINS 90 TABLETS; ENTERIC-COATED DELAYED RELEASED TABLETS SHOULD BE SWALLOWED WHOLE; NOT CHEWED OR BROKEN; STORE PRODUCT AT 25 DEGREES C; PROTECT FROM MOISTURE; Part Name Assigned by Controlling Agency: RABEPRAZOLE SODIUM TABLETS 20MG 90S. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.